Stock of the Day

Ascendis Pharma A/S (ASND)

$172.84

-$4.72 (-2.7%)

Market Cap: $10.54B

About Ascendis Pharma A/S

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Recent News

• Is Ascendis Pharma Gaining or Losing Market Support? (benzinga.com)
• Ascendis Pharma ADR Scores Relative Strength Rating Upgrade (msn.com)
• Ascendis Pharma stock rises following FDA priority review (investing.com)
• Ascendis Pharma Rises as FDA Grants Priority Review for Achondroplasia Treatment (msn.com)
• FDA Accepts TransCon® CNP NDA for Priority Review (globenewswire.com)